News | Proton Therapy | November 06, 2018

Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes

Children receiving proton therapy scored higher in IQ, processing speed and practical function than pediatric patients receiving X-ray radiation

Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes

November 6, 2018 – Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared to X-ray radiation therapy according to a new study. The study was presented at the recent American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 21-24 in San Antonio, Texas, and the International Society of Pediatric Neuro-Oncology Annual Meeting, June 29-July 3 in Denver.

In a retrospective study, Northwestern Medicine researchers compared the outcomes of 125 pediatric patients who received treatment for brain tumors. After accounting for other factors on a multivariable analysis, proton therapy was associated with higher performance in terms of full-scale IQ (10.6 points higher), processing speed (12.6 points higher) and parent-reported practical function (13.8 points higher) relative to X-ray radiation. Other significant factors included patient age, receipt of craniospinal irradiation and the presence of hydrocephalus.

“A child’s brain is more sensitive to radiation. The radiation can disrupt connections being formed in the white matter and prevent the brain from developing normally,” said lead author Jeffrey Paul Gross, M.D., MS, Northwestern University radiation oncology resident.  “If we are able to spare healthy portions of the brain from radiation there is a potential for improved long-term cognitive outcomes.”

Proton therapy uses protons – heavy, positively charged atomic particles – instead of the standard X-rays used in conventional radiation therapy. Protons deposit much of their energy, or dose, directly in the tumor and then stop, whereas conventional radiation continues to deposit the dose beyond the tumor.

“Based on radiation dose profiles, we have always anticipated that children with brain tumors would derive cognitive benefits of proton therapy relative to conventional X-ray therapy,” commented senior author Vinai Gondi, M.D., director of research and education at the Northwestern Medicine Chicago Proton Center. “This study provides our first and most compelling clinical evidence of the importance of using proton therapy to spare as much normal brain tissue as possible.”

Study participants received age-appropriate neuropsychological assessment of IQ, processing speed, visual motor integration, executive function, memory and parent-reported function. The median age of diagnosis was seven years and the median time from treatment to last assessment was four years. The authors note, patients receiving proton therapy had shorter median time from treatment conclusion to last neuropsychological assessment. However, when applying statistical approaches to account for these differences, the cognitive benefits of proton therapy were still observed.

Read more about late-breaking clinical trials at ASTRO 2018.

For more information: www.astro.org

Related Content

Stronger Distribution Networks to Bolster Radiotherapy Patient Positioning Accessories
News | Patient Positioning Radiation Therapy | July 19, 2019
A recent study projects global market revenues for radiotherapy patient positioning accessories will exceed revenues of...
IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
CMS Proposes New Alternative Payment Model for Radiation Oncology
News | Radiation Oncology | July 17, 2019
The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM)...
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
RaySearch Releases Version 3A of RayCare Oncology Information System
Technology | Oncology Information Management Systems (OIMS) | July 15, 2019
RaySearch has released RayCare 3A, a new version of the next-generation oncology information system (OIS). RayCare is...
IBA Launches Monte Carlo Patient QA for Varian Halcyon at AAPM 2019
Technology | Quality Assurance (QA) | July 10, 2019
IBA announced the launch of the latest functionality of the SciMoCa Monte Carlo Patient QA solution at the 61st annual...
Researchers Use Artificial Intelligence to Deliver Personalized Radiation Therapy
News | Radiation Therapy | July 09, 2019
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to...